Form D — Bregma Capital Life Sciences Fund, LP
0002152390-26-000002 · filed Aug 31, 2026
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.7
- Total offering
- —
- Total sold
- $0
- Minimum investment
- $1,000,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Bregma Capital Life Sciences Fund, LP
- CIK
- 2152390
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 224 PRESIDIO AVE
SAN FRANCISCO, CA 94115 - Phone
- 917-415-7223
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Mark E. Karvosky · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
- Bregma Capital GP, LLC · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
- Bregma Capital, LP · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗